Jenny Rinke
Jena, TH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Dysregulation of HIF-1α-regulated and thromboinflammatory genes may contribute to thrombotic risk in patients with BCR::ABL1-negative myeloproliferative neoplasms.
Journal: Journal of thrombosis and haemostasis : JTH
Published: November 28, 2025
MiRNA-based expression signatures in differential diagnosis of enchondroma and chondrosarcoma.
Journal: Journal of bone oncology
Published: November 08, 2025
Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genes.
Journal: Leukemia
Published: June 19, 2025
Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis.
Journal: Annals of hematology
Published: January 30, 2025
Molecular and Clinical Risk Factors Associated with Thrombosis and Bleeding in Myelofibrosis Patients.
Journal: Hamostaseologie
Published: December 21, 2024
Anti-CD19 CAR-T cells are effective in severe idiopathic Lambert-Eaton myasthenic syndrome.
Journal: Cell reports. Medicine
Published: June 20, 2024
Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1 transcript and T315I mutation.
Journal: Leukemia
Published: June 11, 2024
µPhos: a scalable and sensitive platform for high-dimensional phosphoproteomics.
Journal: Molecular systems biology
Published: August 25, 2023
Molecular-defined clonal evolution in patients with classical myeloproliferative neoplasms.
Journal: British journal of haematology
Published: February 11, 2023
Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation.
Journal: Annals of hematology
Published: May 13, 2020
Last Updated: 09/26/2026